69 related articles for article (PubMed ID: 2257570)
1. [Recurrence of idiopathic membranous glomerulopathy].
Knotková V; Nĕmecek K; Ivasková E; Kupková L
Cas Lek Cesk; 1990 Oct; 129(40):1261-5. PubMed ID: 2257570
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
3. [20 years' experience with the treatment of idiopathic membranous glomerulopathy. Retrospective study].
Knotoková V; Nĕmecek K
Cas Lek Cesk; 1990 Mar; 129(10):292-7. PubMed ID: 2340548
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
5. Remissions and relapses in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Altieri P; Locatelli F; Pappalettera M
Nephrol Dial Transplant; 1992; 7 Suppl 1():85-90. PubMed ID: 1337188
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
7. [Clinical course in 51 patients with idiopathic membranous glomerulopathy].
Ardiles L; Mezzano S; Arriagada A; Caorsi I
Rev Med Chil; 1989 Mar; 117(3):266-72. PubMed ID: 2488518
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with idiopathic membranous nephropathy.
Ríhová Z; Merta M; Maixnerová D; Honsová E; Reiterová J; Rysavá R; Zabka J; Tesar V
Prague Med Rep; 2006; 107(2):189-98. PubMed ID: 17066739
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
Murphy BF; Fairley KF; Kincaid-Smith PS
Clin Nephrol; 1988 Oct; 30(4):175-81. PubMed ID: 3214963
[TBL] [Abstract][Full Text] [Related]
12. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and management of membraneous nephropathy.
Pahari DK; Das S; Dutta BN; Banerjee D
J Assoc Physicians India; 1993 Jun; 41(6):350-1. PubMed ID: 8005970
[TBL] [Abstract][Full Text] [Related]
14. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
15. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
Riabov SI; Stavskaia VV; Sheveleva LA
Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
[TBL] [Abstract][Full Text] [Related]
16. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F; Ayili D; Sahiner S
J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
